Number of CAG repeats in POLG1 and its association with Parkinson disease in the Norwegian population

Mitochondrion

Volumn 12, Issue 6, 2012, Pages 640-643

  Balafkan, Novin ^a   Tzoulis, Charalampos ^a,b   Müller, Bernd ^a,b   Haugarvoll, Kristoffer ^a,b   Tysnes, Ole Bjørn ^a,b   Larsen, Jan Petter ^a,c   Bindoff, Laurence A ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c Norwegian Centre for Movement Disorders   (Norway)

Author keywords

Mitochondria; Neurodegeneration; Parkinsonism; Polyglutamine

Indexed keywords

DNA DIRECTED DNA POLYMERASE GAMMA;

ALLELE; ARTICLE; CAG REPEAT; CONTROLLED STUDY; EXON; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; NEUROPATHOLOGY; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PHENOTYPE; POLG1 GENE; POLYMORPHIC LOCUS; PRIORITY JOURNAL;

DNA, MITOCHONDRIAL; DNA-DIRECTED DNA POLYMERASE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NORWAY; PARKINSON DISEASE; REPETITIVE SEQUENCES, NUCLEIC ACID;

EID: 84869085110     PISSN: 15677249     EISSN: 18728278     Source Type: Journal    
DOI: 10.1016/j.mito.2012.08.004     Document Type: Article

References (28)

1. Alves G., Muller B., Herlofson K., HogenEsch I., Telstad W., Aarsland D., Tysnes O.B., Larsen J.P. Incidence of Parkinson's disease in Norway: the Norwegian ParkWest study. J. Neurol. Neurosurg. Psychiatry 2009, 80:851-857.
2. Anvret A., Westerlund M., Sydow O., Willows T., Lind C., Galter D., Belin A.C. Variations of the CAG trinucleotide repeat in DNA polymerase gamma (POLG1) is associated with Parkinson's disease in Sweden. Neurosci. Lett. 2010, 485:117-120.
3. Bindoff L.A., Birch-Machin M.A., Cartlidge N.E., Parker W.D., Turnbull D.M. Respiratory chain abnormalities in skeletal muscle from patients with Parkinson's disease. J. Neurol. Sci. 1991, 104:203-208.
4. Bonifati V., Rizzu P., van Baren M.J., Schaap O., Breedveld G.J., Krieger E., Dekker M.C., Squitieri F., Ibanez P., Joosse M., van Dongen J.W., Vanacore N., van Swieten J.C., Brice A., Meco G., van Duijn C.M., Oostra B.A., Heutink P. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 2003, 299:256-259.
5. Eerola J., Luoma P.T., Peuralinna T., Scholz S., Paisan-Ruiz C., Suomalainen A., Singleton A.B., Tienari P.J. POLG1 polyglutamine tract variants associated with Parkinson's disease. Neurosci. Lett. 2010, 477:1-5.
6. Ferrari G., Lamantea E., Donati A., Filosto M., Briem E., Carrara F., Parini R., Simonati A., Santer R., Zeviani M. Infantile hepatocerebral syndromes associated with mutations in the mitochondrial DNA polymerase-gammaA. Brain 2005, 128:723-731.
7. Gelb D.J., Oliver E., Gilman S. Diagnostic criteria for Parkinson disease. Arch. Neurol. 1999, 56:33-39.
8. Gu G., Reyes P.E., Golden G.T., Woltjer R.L., Hulette C., Montine T.J., Zhang J. Mitochondrial DNA deletions/rearrangements in parkinson disease and related neurodegenerative disorders. J. Neuropathol. Exp. Neurol. 2002, 61:634-639.
9. Hakonen A.H., Heiskanen S., Juvonen V., Lappalainen I., Luoma P.T., Rantamaki M., Goethem G.V., Lofgren A., Hackman P., Paetau A., Kaakkola S., Majamaa K., Varilo T., Udd B., Kaariainen H., Bindoff L.A., Suomalainen A. Mitochondrial DNA polymerase W748S mutation: a common cause of autosomal recessive ataxia with ancient European origin. Am. J. Hum. Genet. 2005, 77:430-441.
10. Hakonen A.H., Goffart S., Marjavaara S., Paetau A., Cooper H., Mattila K., Lampinen M., Sajantila A., Lonnqvist T., Spelbrink J.N., Suomalainen A. Infantile-onset spinocerebellar ataxia and mitochondrial recessive ataxia syndrome are associated with neuronal complex I defect and mtDNA depletion. Hum. Mol. Genet. 2008, 17:3822-3835.
11. Hoehn M.M., Yahr M.D. Parkinsonism: onset, progression and mortality. Neurology 1967, 17:427-442.
12. Hudson G., Tiangyou W., Stutt A., Eccles M., Robinson L., Burn D.J., Chinnery P.F. No association between common POLG1 variants and sporadic idiopathic Parkinson's disease. Mov. Disord. 2009, 24:1092-1094.
13. Jankovic J., McDermott M., Carter J., Gauthier S., Goetz C., Golbe L., Huber S., Koller W., Olanow C., Shoulson I., et al. Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology 1990, 40:1529-1534.
14. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., Yokochi M., Mizuno Y., Shimizu N. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998, 392:605-608.
15. Langston J.W., Ballard P., Tetrud J.W., Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 1983, 219:979-980.
16. Luoma P., Melberg A., Rinne J.O., Kaukonen J.A., Nupponen N.N., Chalmers R.M., Oldfors A., Rautakorpi I., Peltonen L., Majamaa K., Somer H., Suomalainen A. Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study. Lancet 2004, 364:875-882.
17. Luoma P.T., Eerola J., Ahola S., Hakonen A.H., Hellstrom O., Kivisto K.T., Tienari P.J., Suomalainen A. Mitochondrial DNA polymerase gamma variants in idiopathic sporadic Parkinson disease. Neurology 2007, 69:1152-1159. 10.1212/01.wnl.0000276955.23735.eb.
18. Reeve A.K., Krishnan K.J., Elson J.L., Morris C.M., Bender A., Lightowlers R.N., Turnbull D.M. Nature of mitochondrial DNA deletions in substantia nigra neurons. Am. J. Hum. Genet. 2008, 82:228-235.
19. Sham P.C., Curtis D. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann. Hum. Genet. 1995, 59:97-105.
20. Simon D.K., Lin M.T., Zheng L., Liu G.J., Ahn C.H., Kim L.M., Mauck W.M., Twu F., Beal M.F., Johns D.R. Somatic mitochondrial DNA mutations in cortex and substantia nigra in aging and Parkinson's disease. Neurobiol. Aging 2004, 25:71-81.
21. Taanman J.W., Schapira A.H. Analysis of the trinucleotide CAG repeat from the DNA polymerase gamma gene (POLG) in patients with Parkinson's disease. Neurosci. Lett. 2005, 376:56-59.
22. Tiangyou W., Hudson G., Ghezzi D., Ferrari G., Zeviani M., Burn D.J., Chinnery P.F. POLG1 in idiopathic Parkinson disease. Neurology 2006, 67:1698-1700.
23. Tzoulis C., Engelsen B.A., Telstad W., Aasly J., Zeviani M., Winterthun S., Ferrari G., Aarseth J.H., Bindoff L.A. The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 cases. Brain 2006, 129:1685-1692.
24. Tzoulis C., Neckelmann G., Mork S.J., Engelsen B.E., Viscomi C., Moen G., Ersland L., Zeviani M., Bindoff L.A. Localized cerebral energy failure in DNA polymerase gamma-associated encephalopathy syndromes. Brain 2010, 133:1428-1437.
25. Valente E.M., Abou-Sleiman P.M., Caputo V., Muqit M.M., Harvey K., Gispert S., Ali Z., Del Turco D., Bentivoglio A.R., Healy D.G., Albanese A., Nussbaum R., Gonzalez-Maldonado R., Deller T., Salvi S., Cortelli P., Gilks W.P., Latchman D.S., Harvey R.J., Dallapiccola B., Auburger G., Wood N.W. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 2004, 304:1158-1160.
26. Van Goethem G., Dermaut B., Lofgren A., Martin J.J., Van Broeckhoven C. Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions. Nat. Genet. 2001, 28:211-212.
27. Yakubovskaya E., Chen Z., Carrodeguas J.A., Kisker C., Bogenhagen D.F. Functional human mitochondrial DNA polymerase gamma forms a heterotrimer. J. Biol. Chem. 2006, 281:374-382.
28. Zsurka G., Baron M., Stewart J.D., Kornblum C., Bos M., Sassen R., Taylor R.W., Elger C.E., Chinnery P.F., Kunz W.S. Clonally expanded mitochondrial DNA mutations in epileptic individuals with mutated DNA polymerase gamma. J. Neuropathol. Exp. Neurol. 2008, 67:857-866.